Evidence map›Paper›PMID 34190409›Full record

ArticleSmall (Weinheim an der Bergstrasse, Germany)2021

A Membrane-Targeting Photosensitizer with Aggregation-Induced Emission Characteristics for Highly Efficient Photodynamic Combat of Human Coronaviruses.

Ming-Yu Wu, Meijia Gu, Jong-Kai Leung, Xinmei Li, Yuncong Yuan, Chao Shen, Lianrong Wang, Engui Zhao, Sijie Chen

Open access · hybridAbstract read
In one paragraph

Article in Small (Weinheim an der Bergstrasse, Germany), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed
6.2field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 90 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Membrane-Targeting Antivirals.International journal of molecular sciences · 2025
    Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Article
  17. Metal-based complexes against SARS-CoV-2.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2022
    Review
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 3 institutions in 2 countries.

Ming-Yu WuMing Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Hong Kong, 999077, China.
Meijia GuKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, 430071, China.
Jong-Kai LeungMing Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Hong Kong, 999077, China.
Xinmei LiCollege of Life Sciences and China Center for Type Culture Collection, Wuhan University, Wuhan, Hubei, 430071, China.
Yuncong YuanCollege of Life Sciences and China Center for Type Culture Collection, Wuhan University, Wuhan, Hubei, 430071, China.
Chao ShenCollege of Life Sciences and China Center for Type Culture Collection, Wuhan University, Wuhan, Hubei, 430071, China.
Lianrong WangKey Laboratory of Combinatorial Biosynthesis and Drug Discovery, Ministry of Education, School of Pharmaceutical Sciences, Wuhan University, Wuhan, Hubei, 430071, China.
Engui ZhaoSchool of Science, Harbin Institute of Technology, Shenzhen, HIT Campus of University Town, Shenzhen, 518055, China.
Sijie ChenMing Wai Lau Centre for Reparative Medicine, Karolinska Institutet, Hong Kong, 999077, China.ORCID 0000-0001-5263-9189
Wuhan University · CNMing Wai Lau Centre for Reparative Medicine · HKShenzhen Institute of Information Technology · CN

Funding

Applied Basic Research of Sichuan Province 2021YJ0397National Key Research and Development Program of China 2019YFA0904300National Natural Science Foundation of China 21708030National Natural Science Foundation of China 22005050National Natural Science Foundation of China 31720103906
6 · The paper itself

Abstract

COVID-19 pandemic, caused by severe acute respiratory syndrome coronavirus 2, has resulted in global social and economic disruption, putting the world economy to the largest global recession since the Great Depression. To control the spread of COVID-19, cutting off the transmission route is a critical step. In this work, the efficient inactivation of human coronavirus with photodynamic therapy (PDT) by employing photosensitizers with aggregation-induced emission characteristics (DTTPB) is reported. DTTPB is designed to bear a hydrophilic head and two hydrophobic tails, mimicking the structure of phospholipids on biological membranes. DTTPB demonstrates a broad absorption band covering the whole visible light range and high molar absorptivity, as well as excellent reactive oxygen species sensitizing ability, making it an excellent candidate for PDT. Besides, DTTPB can target membrane structure, and bind to the envelope of human coronaviruses. Upon light irradiation, DTTPB demonstrates highly effective antiviral behavior: human coronavirus treated with DTTPB and white-light irradiation can be efficiently inactivated with complete loss of infectivity, as revealed by the significant decrease of virus RNA and proteins in host cells. Thus, DTTPB sensitized PDT can efficiently prevent the infection and the spread of human coronavirus, which provides a new avenue for photodynamic combating of COVID-19.

Indexed as

COVID-19PhotochemotherapyHumansPandemicsPhotosensitizing AgentsSARS-CoV-2Photosensitizing Agentsaggregation-induced emissionhuman coronavirusesmembrane targetingphotodynamic therapyphotosensitizers

Identifiers

PMID34190409
PMCPMC8420407
OpenAlexW3174192977

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.